Human Serum, Normal, Single Donor
Screening samples (34015-0) are 1–3 mL of single-donor off-the-clot human serum; the matching reserve unit (34015-1) is that donor's whole serum unit, typically 150–330 mL. Samples are $5.00 each; reserve units are priced at $5.00/mL and can be held for up to 30 days.
Specifications
Release criteria
3 more criteria Show less
Lead time on this item is currently: 2-4 Weeks
Need help? Ask a Specialist Contact UsOR +1 (800) 643-3426
Product Overview
| Species: | Human |
|---|---|
| Product Types: | Serum |
| Source: | OTC Serum |
| Pooling: | Single Donor |
| Donor Sex: | Mixed |
| Physical State: | Frozen Liquid |
| Application Notes: | Samples ideal for screening purposes. Reserve available. |
| Testing: | Each donor unit was tested prior to pooling according to FDA guidelines for the detection of Hepatitis B Surface Antigen, Antibodies to HIV and HVC, HIV-1 RNA, HBV DNA, HCV RNA, WNV RNA, and Syphilis. Each donor has been tested according to FDA guidelines for T. Cruzi (Chagas). All units yielded NON-REACTIVE/NEGATIVE results for each test performed. All blood is collected in the United States of America from human donors in FDA licensed centers and tested with FDA approved test kits. No test method can provide total assurance that Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus or other infectious agents are absent. |
| Storage Conditions: | -70°C or below |
| Shipping Conditions: | Dry ice |
| Packaging: | Cryovial, Poly bottle |
| Expiration: | 1 year from date of receipt when stored continuously at -70°C or below; avoid repeated freeze/thaw. Product quality is guaranteed to meet Pel-Freez Biologicals' specifications for this period when stored as indicated. |
Product Applications
- Hemolytic complement assay
- ELISA
- Assay diluent & negative matrix
- Assay controls & calibrators
- Cell culture
- Toxicology assays
- Vaccine development
- Tissue typing
- In vitro diagnostics
Documents & Datasheets
Safety Datasheet
Certificate of Analysis
| Lot | Issued | |
|---|---|---|
| 22348-3243 | Aug 13, 2026 | Download |
| 22348-7958 | Aug 13, 2026 | Download |
| 10648 | Jul 20, 2026 | Download |
| 16348 | Jun 23, 2026 | Download |
| 14848 | May 29, 2026 | Download |
| 05848 | Mar 4, 2026 | Download |
| 04248 | Feb 17, 2026 | Download |
| 00248 | Jan 8, 2026 | Download |
| 31547 | Nov 18, 2025 | Download |
| 26947 | Sep 29, 2025 | Download |
Show all 30 certificates
| 08547 | Apr 4, 2025 | Download |
| 08647 | Apr 4, 2025 | Download |
| 08447 | Mar 25, 2025 | Download |
| 05847 | Feb 28, 2025 | Download |
| 28546 | Oct 21, 2024 | Download |
| 21644 | Aug 22, 2022 | Download |
| 32743 | Nov 24, 2021 | Download |
| 26643 | Sep 24, 2021 | Download |
| 16543 | Jul 29, 2021 | Download |
| 16943 | Jul 29, 2021 | Download |
| 17943 | Jul 29, 2021 | Download |
| 15843 | Jul 29, 2021 | Download |
| 14843 | Jul 29, 2021 | Download |
| 09243 | May 11, 2021 | Download |
| 09843 | May 11, 2021 | Download |
| 10943 | May 11, 2021 | Download |
| 11343 | May 11, 2021 | Download |
| 13341 | May 15, 2019 | Download |
| 25740 | Sep 20, 2018 | Download |
| 22740 | Aug 15, 2018 | Download |
Frequently Asked Questions
How should I thaw frozen serum or plasma?
Can I refreeze serum after it has thawed?
My thawed serum is cloudy or has particles in it. Is it still good?
Product References
- Salic acid protects nontypeable Haemophilus influenza from natural IgM and promotes survival in murine respiratory tract.
Jackson, M. D., Wong, S. M. & Akerley, B. J. Sialic acid protects nontypeable haemophilus influenzae from natural igm and promotes survival in murine respiratory tract. Infect. Immun. 89, (2021).
- Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
Shaughnessy, J. et al. Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae. Front. Immunol. 11, 2680 (2020).
- Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection
Parzych, E. M. et al. Synthetic dna delivery of an optimized and engineered monoclonal antibody provides rapid and prolonged protection against experimental gonococcal infection. MBio 12, 1–13 (2021).
- Neisseria meningitidis urethritis outbreak isolates express a novel factor H binding protein variant that is a potential target of group B-directed meningococcal (MenB) …
Tzeng, Y. L. et al. Neisseria meningitidis urethritis outbreak isolates express a novel factor H binding protein variant that is a potential target of group B-Directed meningococcal (menb) vaccines. Infect. Immun. 88, (2020).
- Vaccination with Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model
Fernandez, J. et al. Vaccination with Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model . J. Infect. Dis. (2021).
- Preclinical efficacy of a lipooligosaccharide peptide mimic candidate gonococcal vaccine
Gulati, S. et al. Preclinical efficacy of a lipooligosaccharide peptide mimic candidate Gonococcal vaccine. MBio 10, (2019).
- Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae
Gulati, S., Rice, P. A. & Ram, S. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae. in Methods in Molecular Biology vol. 1997 267–280 (Humana Press Inc., 2019).
- Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria
Shaughnessy, J. et al. Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae. Front. Immunol. 11, (2020).
